Mark James Litton, Chief Business Officer at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 25,000 shares at $30.06 ($751K) on 2016-05-27, disclosed to the SEC on 2016-06-01.
Open-market sale of $751k ALDR by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.06 | 5,280 | $159K | 21.1% |
| 2 | $30.05 | 19,720 | $593K | 78.9% |
| Total | $30.05 avg | 25,000 | $751K | 100% |
| Filing → |
| ALDR | SELL | 2017-01-09 | $219K | — | Filing → |
| ALDR | SELL | 2016-10-19 | $165K | — | Filing → |
| ALDR | SELL | 2016-06-15 | $171K | — | Filing → |